Inside EU Health Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI; ECDC issues warning on Doxy-PEP Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI principles; ECDC issues warning on Doxy-PEP
Inside EU Health Inside EU Health: Climate inaction and health; ACT EU goes multilingual; and the US sets new rules for biosimilars Climate inaction and health; ACT EU goes multilingual; and the US sets news rules for biosimilars
EMA EMA marks 30 years since first EU-wide medicine approval The European Medicines Agency reaffirms its mission to ensure safe, effective treatments across the EU
